Scutellarin alleviates depression-like behaviors induced by LPS in mice partially through inhibition of astrocyte-mediated neuroinflammation

Neurosci Lett. 2021 Nov 20:765:136284. doi: 10.1016/j.neulet.2021.136284. Epub 2021 Oct 5.

Abstract

Depression is a kind of common mental disorder associated with neuroinflammation, and astrocytes play a vital role in regulating and mediating neuroinflammation in central nervous system. Scutellarin has significant anti-inflammatory and neuroprotective effects. However, whether scutellarin exerts antidepressant effect remains unknown. In present study, it was found that scutellarin suppressed LPS-induced neuroinflammation in the hippocampus and alleviated depression-like behaviors in mice. In addition, scutellarin inhibited LPS-induced elevation of TNFα, IL-1β, IL-6 and iNOS, and reversed the downregulation of IL-4 and BDNF in astrocytes in vitro. Furthermore, the activated TLR4/NF-κB pathway in LPS-treated astrocytes was suppressed by scutellarin. Collectively, these results suggest that scutellarin ameliorates depression-like behaviors induced by neuroinflammation partially through inhibiting the TLR4/NF-κB pathway in astrocytes.

Keywords: Astrocyte; Depression; Neuroinflammation; Scutellarin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Apigenin / pharmacology*
  • Astrocytes / drug effects*
  • Astrocytes / immunology*
  • Depression / immunology*
  • Glucuronates / pharmacology*
  • Hippocampus / drug effects
  • Lipopolysaccharides / immunology
  • Lipopolysaccharides / toxicity
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Neuroinflammatory Diseases / immunology*

Substances

  • Anti-Inflammatory Agents
  • Glucuronates
  • Lipopolysaccharides
  • scutellarin
  • Apigenin